| Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation E Wang, H Zhou, B Nadorp, G Cayanan, X Chen, AH Yeaton, S Nomikou, ... Cell Stem Cell 28 (4), 718-731. e6, 2021 | 55 | 2021 |
| Functional impact of intramolecular cleavage and dissociation of adhesion G protein–coupled receptor GPR133 (ADGRD1) on canonical signaling JD Frenster, G Stephan, N Ravn-Boess, D Bready, J Wilcox, B Kieslich, ... Journal of Biological Chemistry 296, 2021 | 33 | 2021 |
| Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypes JD Frenster, M Kader, S Kamen, J Sun, L Chiriboga, J Serrano, D Bready, ... Neuro-oncology advances 2 (1), vdaa053, 2020 | 22 | 2020 |
| Adhesion G protein-coupled receptors in glioblastoma G Stephan, N Ravn-Boess, DG Placantonakis Neuro-oncology advances 3 (1), vdab046, 2021 | 15 | 2021 |
| The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability N Ravn-Boess, N Roy, T Hattori, D Bready, H Donaldson, C Lawson, ... Cell reports 42 (11), 2023 | 9 | 2023 |
| PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma JD Frenster, H Erdjument-Bromage, G Stephan, N Ravn-Boess, S Wang, ... Cell reports 42 (7), 2023 | 9* | 2023 |
| Modulation of GPR133 (ADGRD1) signaling by its intracellular interaction partner extended synaptotagmin 1 G Stephan, S Haddock, S Wang, H Erdjument-Bromage, W Liu, ... Cell Reports 43 (5), 2024 | 1* | 2024 |
| CSIG-22. PHARMACOLOGIC INHIBITION AND KNOCKDOWN OF CAMK2 IMPAIR GROWTH OF PATIENT-DERIVED GLIOBLASTOMA CULTURES R Ronnen, S Wang, S Haddock, N Ravn-Boess, D Golub, G Stephan, ... Neuro-Oncology 26 (Supplement_8), viii68-viii68, 2024 | | 2024 |
| PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma. JD Frenster, H Erdjument-Bromage, G Stephan, N Ravn-Boess, S Wang, ... Cell Reports 42 (7), 112679-112679, 2023 | | 2023 |
| Exploring the Function and Therapeutic Potential of the Adhesion G Protein-Coupled Receptor CD97 (ADGRE5) in Glioblastoma N Ravn-Boess New York University, 2023 | | 2023 |
